<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04721951</url>
  </required_header>
  <id_info>
    <org_study_id>CO2-EVAR</org_study_id>
    <nct_id>NCT04721951</nct_id>
  </id_info>
  <brief_title>An Innovative Approach to Automated Carbon Dioxide Angiography During Endovascular Abdominal Aortic Aneurysm Repair</brief_title>
  <acronym>CO2-EVAR</acronym>
  <official_title>CO2-EVAR - An Innovative Approach to Automated Carbon Dioxide Angiography During Endovascular Abdominal Aortic Aneurysm Repair - (Proof of Concept Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to perform Endovascular Aortic Repair procedures with CO2-Angiography using a&#xD;
      standardized an operative Protocol&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Technical Success</measure>
    <time_frame>30 Days</time_frame>
    <description>Technical success to assess the renal ostia and the hypogastric arteries (defined as 100% accuracy correlated to the iodinated contrast agent angiography or IVUS/FUSION techniques)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Image Quality</measure>
    <time_frame>30 Days</time_frame>
    <description>Image quality for guiding the procedure defined as good for stent-graft implantation or low not allowing stent-graft implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoleak Detection</measure>
    <time_frame>30 Days</time_frame>
    <description>Type I-IV endoleak detection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO2 Quantity</measure>
    <time_frame>30 Days</time_frame>
    <description>Amount of CO2 at each deployment step (renal arteries, right/left hypogastric artery, final angiography)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Exclusion</measure>
    <time_frame>30 Days</time_frame>
    <description>Aneurysm exclusion without type I or III endoleaks at the CT scan at discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>30 Days</time_frame>
    <description>Any adverse event within 24 hours</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular Aortic Repair using Carbon Dioxide Angiography</intervention_name>
    <description>Endovascular Aortic Repair using Carbon Dioxide Angiography</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with AAA, undergoing EVAR&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Male, female&#xD;
&#xD;
          -  Patients with indication for AAA&#xD;
&#xD;
          -  Informed consent achievement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe COPD (Chronic Obstructive Pulmonary Disease)&#xD;
&#xD;
          -  Known atrium- or ventricular septal defect with right-left-shunt&#xD;
&#xD;
          -  Severe renal arteries atherosclerosis&#xD;
&#xD;
          -  Ruptured AAA&#xD;
&#xD;
          -  Current partecipation in other interventional studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Gargiulo, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of experimental diagnostic and specialty medicine - Vascular Surgery - University of Bologna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Vacirca, MD</last_name>
    <phone>3480455374</phone>
    <phone_ext>0039</phone_ext>
    <email>andrea.vacirca3@unibo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mauro Gargiulo, Prof</last_name>
    <phone>0512143288</phone>
    <phone_ext>0039</phone_ext>
    <email>mauro.gargiulo2@unibo.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of experimental diagnostic and specialty medicine - Vascular Surgery</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Vacirca, MD</last_name>
      <phone>3480455374</phone>
      <phone_ext>0039</phone_ext>
      <email>andrea.vacirca3@unibo.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bologna</investigator_affiliation>
    <investigator_full_name>Andrea Vacirca</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Endovascular Aortic Repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

